Intervention is viable option low-risk patients with normal function in left ventricle
Patients with normal left ventricular function who undergo elective unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents had favorable outcomes according to new research. Results of the multicenter, retrospective study are reported in the June issue of Catheterization and Cardiovascular Interventions, a journal published by Wiley-Blackwell on behalf of The Society Cardiovascular Angiography and Interventions .
patients with ULMCA disease, coronary artery bypass grafting , known commonly as heart bypass surgery, is the standard of care based on medical evidence that shows a survival advantage with this intervention. Current guidelines PCI state that ULMCA stenting may be an option patients who are at high risk adverse surgical outcomes, but have a low risk procedural complications. In patients with severe aortic calcification, cerebrovascular disease, or limited life expectancy angioplasty may be elected over heart bypass surgery.
The present study, led by Michael Lee, MD, FSCAI, from the University of California, Los Angeles Medical Center evaluated the safety and efficacy of ULMCA PCI with DES in patients with normal left ventricular function. Researchers used data from a multicenter international registry, identifying 221 patients who underwent elective PCI ULMCA disease between 2002 and 2009. Patients in
- Predicting Who Will — and Won’t — Survive a Heart Attack
- Long Term Data Presented at ESC 2010 Further Support the Benefit of TheSirolimus Drug-Eluting Stent Compared to The ENDEAVOR(R) Zotarolimus-Eluting Stent in Important High-Risk Subgroups
- Experts Question Use of Ankle Blood Pressure to Gauge Heart Risks
- Chronic constipation tied to women’s heart risks
- Dialysis Catheters Tied to Higher Risk for Infection, Death, Study Finds